Novel Intraoperative Probe Developed for Cancer Surgery
By MedImaging International staff writers Posted on 03 Jul 2017 |
Image: A depiction of the new multimodal probe in use during surgery, together with a Magnetic Resonance Imaging (MRI) scan of a brain cancer patient, showing the tumor in red (Photo courtesy of Frédéric Leblond and Kevin Petrecca).
An innovative intraoperative probe for detecting different types of tumor cells has been developed by researchers in Canada.
The multimodal hand-held Raman optical spectroscopy probe enables surgeons to detect nearly all cancer cells during brain surgery.
The scientists from the Polytechnique Montréal (Montréal, Canada), and two other hospitals and Universities developed the hand-held Raman spectroscopy probe. The device is now accurate, sensitive and specific enough for detecting brain, colon, lung, and skin cancer cells. During intraoperative testing the probe showed nearly 100% sensitivity for detecting cancer cells. Details of the breakthrough technology were published in the June 28, 2017, issue of the American Association for Cancer Research journal Cancer Research.
The unique feature of the new second-generation system is that it can be used in real-time, during a surgical procedure, to detect cancer cells. The multimodal probe uses intrinsic fluorescence spectroscopy, and diffuse-reflectance spectroscopy technologies. A randomized clinical trial is currently under way using the first-generation Raman spectroscopy probe for patients with gliomas, and will help researchers develop a protocol for a clinical trial of the new second-generation multimodal probe.
Chief of Neurosurgery, brain cancer researcher Dr. Petrecca, said, "Minimizing, or completely eliminating, the number of cancer cells during surgery is a critical part of cancer treatment, yet detecting cancer cells during surgery is challenging. Often it is impossible to visually distinguish cancer from normal brain, so invasive brain cancer cells frequently remain after surgery, leading to cancer recurrence and a worse prognosis. Surgically minimizing the number of cancer cells improves patient outcomes. A technology with extremely high accuracy is necessary, since surgeons will be using this information to help determine if tissues contain cancer cells or not."
Related Links:
Polytechnique Montréal
The multimodal hand-held Raman optical spectroscopy probe enables surgeons to detect nearly all cancer cells during brain surgery.
The scientists from the Polytechnique Montréal (Montréal, Canada), and two other hospitals and Universities developed the hand-held Raman spectroscopy probe. The device is now accurate, sensitive and specific enough for detecting brain, colon, lung, and skin cancer cells. During intraoperative testing the probe showed nearly 100% sensitivity for detecting cancer cells. Details of the breakthrough technology were published in the June 28, 2017, issue of the American Association for Cancer Research journal Cancer Research.
The unique feature of the new second-generation system is that it can be used in real-time, during a surgical procedure, to detect cancer cells. The multimodal probe uses intrinsic fluorescence spectroscopy, and diffuse-reflectance spectroscopy technologies. A randomized clinical trial is currently under way using the first-generation Raman spectroscopy probe for patients with gliomas, and will help researchers develop a protocol for a clinical trial of the new second-generation multimodal probe.
Chief of Neurosurgery, brain cancer researcher Dr. Petrecca, said, "Minimizing, or completely eliminating, the number of cancer cells during surgery is a critical part of cancer treatment, yet detecting cancer cells during surgery is challenging. Often it is impossible to visually distinguish cancer from normal brain, so invasive brain cancer cells frequently remain after surgery, leading to cancer recurrence and a worse prognosis. Surgically minimizing the number of cancer cells improves patient outcomes. A technology with extremely high accuracy is necessary, since surgeons will be using this information to help determine if tissues contain cancer cells or not."
Related Links:
Polytechnique Montréal
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer